| Sarah Marie Krebs, | |
|
3761 Johnson Hall Dr, Masonic Home, KY 40041-9998 | |
| (502) 203-1918 | |
| Not Available |
| Full Name | Sarah Marie Krebs |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3761 Johnson Hall Dr, Masonic Home, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356193841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Marie Krebs, 90 Howard Dr, Shelbyville, KY 40065-8138 Ph: () - | Sarah Marie Krebs, 3761 Johnson Hall Dr, Masonic Home, KY 40041-9998 Ph: (502) 203-1918 |
News Archive
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported that it has entered into a new agreement with GlaxoSmithKline (GSK), that terminates and replaces a prior collaborative research and license agreement between NPS and GSK from 1993, which focused on the discovery and development of small molecule antagonists of the calcium receptor that increase secretion of parathyroid hormone.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.
Patients who are bedridden or unable to move their legs are often at risk of developing Deep Vein Thrombosis (DVT), a potentially life-threatening condition caused by blood clots forming along the lower extremity veins of the legs. A team of researchers from the National University of Singapore's Yong Loo Lin School of Medicine and Faculty of Engineering has invented a novel sock that can help prevent DVT and improve survival rates of patients.
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today's clinical or behavioral tools for assessing relapse risk.
› Verified 9 days ago
Courtney M Marra, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3761 Johnson Hall Dr, Masonic Home, KY 40041 Phone: 502-633-1007 | |
Destiny Satchell Nowlin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3761 Johnson Hall Dr, Masonic Home, KY 40041 Phone: 502-293-1695 | |
Joanna Still, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3761 Johnson Hall Dr, Masonic Home, KY 40041 Phone: 502-633-1007 Fax: 502-805-1511 | |
Mrs. Sally Phillips Junkins, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3761 Johnson Hall Dr, Masonic Home, KY 40041 Phone: 502-293-1695 Fax: 502-805-1511 |